Response Genetics Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2010
2011
2012
2013
2014
Net Income before Extraordinaries
4,670.40
5,702.40
7,757.10
8,020.50
13,699.40
Depreciation, Depletion & Amortization
465.70
366.70
470.10
633.00
827.60
Other Funds
1,279.00
2,192.30
2,169.60
3,640.00
6,762.40
Funds from Operations
2,925.70
3,143.40
5,117.40
3,747.50
6,109.40
Changes in Working Capital
3,566.00
1,940.90
2,893.90
2,741.30
8,190.70
Net Operating Cash Flow
6,491.70
5,084.30
8,011.30
6,488.80
14,300.10
Capital Expenditures
391.50
390.80
956.60
807.90
104.00
Sale of Fixed Assets & Businesses
-
-
-
-
2.00
Net Investing Cash Flow
391.50
390.80
956.60
807.90
102.00
Issuance/Reduction of Debt, Net
-
938.90
147.60
188.10
8,445.30
Net Financing Cash Flow
3,953.50
3,128.50
16,304.90
6,407.20
8,468.50
Net Change in Cash
2,938.30
2,419.80
7,341.20
892.90
5,926.10
Free Cash Flow
6,883.20
5,475.10
8,436.80
7,117.30
14,350.00
Change in Capital Stock
3,953.50
2,189.60
16,452.50
6,595.30
23.20
Exchange Rate Effect
8.60
73.20
4.10
3.50
7.50
About Response Genetics
View Profile
